BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18374401)

  • 1. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
    Li AJ; Scoles DR; Armstrong KU; Karlan BY
    Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology.
    Li AJ; Elmore RG; Pavelka JC; Karlan BY
    Gynecol Oncol; 2007 Dec; 107(3):420-3. PubMed ID: 17825390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.
    Li AJ; McAllister P; Karlan BY
    Gynecol Oncol; 2010 Jan; 116(1):105-8. PubMed ID: 19818997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen mediation of thrombocytosis in epithelial ovarian cancer biology.
    Li AJ; Karlan BY
    Clin Cancer Res; 2005 Nov; 11(22):8015-8. PubMed ID: 16299230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.
    Li AJ; Baldwin RL; Karlan BY
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3667-73. PubMed ID: 14506156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men.
    Di Fabio F; Alvarado C; Gologan A; Youssef E; Voda L; Mitmaker E; Beitel LK; Gordon PH; Trifiro M
    J Surg Res; 2009 Jun; 154(1):38-44. PubMed ID: 19062046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shorter CAG repeat length in the AR gene is associated with poor outcome in head and neck cancer.
    Rosa FE; dos Santos RM; Poli-Frederico RC; Canevari Rde A; Nishimoto IN; Magrin J; Rainho CA; Kowalski LP; Rogatto SR
    Arch Oral Biol; 2007 Aug; 52(8):732-9. PubMed ID: 17321486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a short CAG (glutamine) repeat on human androgen receptor function.
    Ding D; Xu L; Menon M; Reddy GP; Barrack ER
    Prostate; 2004 Jan; 58(1):23-32. PubMed ID: 14673949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor gene cytosine, adenine, and guanine trinucleotide repeats in patients with endometriosis.
    Lattuada D; Viganò P; Somigliana E; Odorizzi MP; Vignali M; Di Blasio AM
    J Soc Gynecol Investig; 2004 May; 11(4):237-40. PubMed ID: 15120698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
    Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
    IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
    Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
    Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action.
    Ding D; Xu L; Menon M; Reddy GP; Barrack ER
    Prostate; 2005 Feb; 62(2):133-9. PubMed ID: 15389799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B; Mayer D
    Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
    Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R
    Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic Cytosine-Adenine-Guanine Repeat Length of Androgen Receptor Gene and Gender Incongruence in Trans Women: A Systematic Review and Meta-Analysis of Case-Control Studies.
    D'Andrea S; Pallotti F; Senofonte G; Castellini C; Paoli D; Lombardo F; Lenzi A; Francavilla S; Francavilla F; Barbonetti A
    J Sex Med; 2020 Mar; 17(3):543-550. PubMed ID: 31926901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
    Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C
    J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome.
    Jääskeläinen J; Korhonen S; Voutilainen R; Hippeläinen M; Heinonen S
    Fertil Steril; 2005 Jun; 83(6):1724-8. PubMed ID: 15950642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women.
    Brum IS; Spritzer PM; Paris F; Maturana MA; Audran F; Sultan C
    J Soc Gynecol Investig; 2005 Feb; 12(2):135-41. PubMed ID: 15695110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer CAG repeat length in the androgen receptor gene is associated with premature ovarian failure.
    Chatterjee S; Singh R; Kadam S; Maitra A; Thangaraj K; Meherji P; Modi D
    Hum Reprod; 2009 Dec; 24(12):3230-5. PubMed ID: 19684044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
    Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
    Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.